- Home
- SB vs TNGX Comparison
SB vs TNGX Comparison
Compare SB & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SB | TNGX |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | Monaco | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.9M | 1.4B |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | SB | TNGX |
|---|---|---|
| Price | $4.94 | $9.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $6.00 | ★ $12.50 |
| AVG Volume (30 Days) | 589.4K | ★ 2.6M |
| Earning Date | 11-25-2025 | 11-04-2025 |
| Dividend Yield | ★ 4.07% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $274,661,000.00 | $66,501,000.00 |
| Revenue This Year | N/A | $53.01 |
| Revenue Next Year | $13.74 | N/A |
| P/E Ratio | $13.90 | ★ N/A |
| Revenue Growth | N/A | ★ 53.29 |
| 52 Week Low | $3.02 | $1.03 |
| 52 Week High | $5.54 | $11.20 |
Technical Indicators
Market Signals| Indicator | SB | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 52.39 |
| Support Level | $5.20 | $8.89 |
| Resistance Level | $5.54 | $10.22 |
| Average True Range (ATR) | 0.15 | 0.63 |
| MACD | -0.04 | -0.14 |
| Stochastic Oscillator | 15.99 | 20.91 |
Price Performance
Historical ComparisonAbout SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.